blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1720868

EP1720868 - PYRIMIDINE DERIVATIVES FOR USE AS VANILLOID RECEPTOR LIGANDS AND THEIR USE IN THE TREATMENT OF PAIN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.09.2010
Database last updated on 03.10.2024
Most recent event   Tooltip19.10.2012Lapse of the patent in a contracting state
New state(s): TR		published on 21.11.2012  [2012/47]
Applicant(s)For all designated states
AMGEN INC.
M/S 27-4-A One Amgen Center Drive
Thousand Oaks, CA 91320-1799 / US
[2006/46]
Inventor(s)01 / WANG, Hui-Ling
822 Lynnmere Drive
Thousand Oaks, California 91360 / US
02 / BALAN, Chenera
4586 Via Rodeo
Thousand Oaks, California 91320 / US
03 / DOHERTY, Elizabeth, M.
1542 Campbell Avenue
Thousand Oaks, CA 91360 / US
04 / FALSEY, James, Richard
4943 Hollyglen Court
Moorpark, California 93021 / US
05 / GORE, Vijay, Keshav
4302 Via Encanto
Thousand Oaks, California 91320 / US
06 / KATON, Jodie
6330 Rand Avenue No.E115
Woodland Hills, CA 91367 / US
07 / NORMAN, Mark, H.
130 Venus Street
Thousand Oaks, California 91360 / US
 [2006/46]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstrasse 4
80802 München / DE
[N/P]
Former [2006/46]Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
Maximilianstrasse 58
80538 München / DE
Application number, filing date05722962.711.02.2005
[2006/46]
WO2005US04378
Priority number, dateUS20040543896P11.02.2004         Original published format: US 543896 P
[2006/46]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005077944
Date:25.08.2005
Language:EN
[2005/34]
Type: A1 Application with search report 
No.:EP1720868
Date:15.11.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 25.08.2005 takes the place of the publication of the European patent application.
[2006/46]
Type: B1 Patent specification 
No.:EP1720868
Date:04.11.2009
Language:EN
[2009/45]
Search report(s)International search report - published on:EP25.08.2005
ClassificationIPC:C07D417/12, C07D417/14, C07D401/12, C07D403/12, C07D405/12, C07D413/12, C07D471/04, A61K31/506, A61P29/00
[2006/46]
CPC:
C07D401/12 (EP,KR,US); A61K31/506 (KR); A61P1/04 (EP);
A61P1/10 (EP); A61P1/14 (EP); A61P11/00 (EP);
A61P11/02 (EP); A61P11/06 (EP); A61P13/10 (EP);
A61P15/00 (EP); A61P17/00 (EP); A61P17/02 (EP);
A61P17/06 (EP); A61P17/14 (EP); A61P19/02 (EP);
A61P25/04 (EP); A61P25/06 (EP); A61P25/22 (EP);
A61P25/24 (EP); A61P27/02 (EP); A61P29/00 (EP);
A61P37/08 (EP); A61P43/00 (EP); C07D403/12 (EP,US);
C07D405/12 (EP,US); C07D413/12 (EP,US); C07D417/12 (EP,US);
C07D417/14 (EP,US); C07D471/04 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/46]
Extension statesAL24.08.2006
BA24.08.2006
HR24.08.2006
LV24.08.2006
MK24.08.2006
YU24.08.2006
TitleGerman:PYRIMIDINDERIVATE ZUR VERWENDUNG ALS VANILLOIDREZEPTORLIGANDEN UND DEREN VERWENDUNG BEI DER BEHANDLUNG VON SCHMERZEN[2006/46]
English:PYRIMIDINE DERIVATIVES FOR USE AS VANILLOID RECEPTOR LIGANDS AND THEIR USE IN THE TREATMENT OF PAIN[2006/46]
French:DERIVES DE PYRIMIDINE UTILISES COMME LIGANDS DE RECEPTEUR DE VANILLOIDE ET LEUR UTILISATION DANS LE TRAITEMENT DE LA DOULEUR[2006/46]
Entry into regional phase24.08.2006National basic fee paid 
24.08.2006Designation fee(s) paid 
24.08.2006Examination fee paid 
Examination procedure24.08.2006Examination requested  [2006/46]
24.04.2007Despatch of a communication from the examining division (Time limit: M04)
29.06.2007Reply to a communication from the examining division
02.12.2008Despatch of a communication from the examining division (Time limit: M04)
09.04.2009Reply to a communication from the examining division
11.05.2009Communication of intention to grant the patent
18.09.2009Fee for grant paid
18.09.2009Fee for publishing/printing paid
Opposition(s)05.08.2010No opposition filed within time limit [2010/41]
Fees paidRenewal fee
14.02.2007Renewal fee patent year 03
13.02.2008Renewal fee patent year 04
13.02.2009Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT04.11.2009
BE04.11.2009
CY04.11.2009
CZ04.11.2009
DK04.11.2009
EE04.11.2009
FI04.11.2009
LT04.11.2009
NL04.11.2009
PL04.11.2009
RO04.11.2009
SE04.11.2009
SI04.11.2009
SK04.11.2009
TR04.11.2009
BG04.02.2010
GR05.02.2010
GB11.02.2010
IE11.02.2010
IT11.02.2010
LU11.02.2010
ES12.02.2010
CH28.02.2010
LI28.02.2010
FR01.03.2010
MC01.03.2010
IS04.03.2010
PT04.03.2010
HU05.05.2010
[2012/47]
Former [2012/44]AT04.11.2009
BE04.11.2009
CY04.11.2009
CZ04.11.2009
DK04.11.2009
EE04.11.2009
FI04.11.2009
LT04.11.2009
NL04.11.2009
PL04.11.2009
RO04.11.2009
SE04.11.2009
SI04.11.2009
SK04.11.2009
BG04.02.2010
GR05.02.2010
GB11.02.2010
IE11.02.2010
IT11.02.2010
LU11.02.2010
ES12.02.2010
CH28.02.2010
LI28.02.2010
FR01.03.2010
MC01.03.2010
IS04.03.2010
PT04.03.2010
HU05.05.2010
Former [2012/43]AT04.11.2009
BE04.11.2009
CY04.11.2009
CZ04.11.2009
DK04.11.2009
EE04.11.2009
FI04.11.2009
LT04.11.2009
PL04.11.2009
RO04.11.2009
SE04.11.2009
SI04.11.2009
SK04.11.2009
BG04.02.2010
GR05.02.2010
GB11.02.2010
IE11.02.2010
IT11.02.2010
LU11.02.2010
ES12.02.2010
CH28.02.2010
LI28.02.2010
FR01.03.2010
MC01.03.2010
IS04.03.2010
PT04.03.2010
HU05.05.2010
Former [2012/42]AT04.11.2009
BE04.11.2009
CY04.11.2009
CZ04.11.2009
DK04.11.2009
EE04.11.2009
FI04.11.2009
LT04.11.2009
PL04.11.2009
RO04.11.2009
SE04.11.2009
SI04.11.2009
SK04.11.2009
BG04.02.2010
GR05.02.2010
GB11.02.2010
IE11.02.2010
IT11.02.2010
ES12.02.2010
CH28.02.2010
LI28.02.2010
FR01.03.2010
MC01.03.2010
IS04.03.2010
PT04.03.2010
HU05.05.2010
Former [2011/16]AT04.11.2009
BE04.11.2009
CY04.11.2009
CZ04.11.2009
DK04.11.2009
EE04.11.2009
FI04.11.2009
LT04.11.2009
PL04.11.2009
RO04.11.2009
SE04.11.2009
SI04.11.2009
SK04.11.2009
BG04.02.2010
GR05.02.2010
GB11.02.2010
IE11.02.2010
IT11.02.2010
CH28.02.2010
LI28.02.2010
FR01.03.2010
MC01.03.2010
IS04.03.2010
PT04.03.2010
Former [2011/07]AT04.11.2009
BE04.11.2009
CY04.11.2009
CZ04.11.2009
DK04.11.2009
EE04.11.2009
FI04.11.2009
LT04.11.2009
PL04.11.2009
RO04.11.2009
SE04.11.2009
SI04.11.2009
SK04.11.2009
BG04.02.2010
GR05.02.2010
IE11.02.2010
CH28.02.2010
LI28.02.2010
FR01.03.2010
MC01.03.2010
IS04.03.2010
PT04.03.2010
Former [2010/52]AT04.11.2009
BE04.11.2009
CY04.11.2009
CZ04.11.2009
DK04.11.2009
EE04.11.2009
FI04.11.2009
LT04.11.2009
PL04.11.2009
RO04.11.2009
SE04.11.2009
SI04.11.2009
SK04.11.2009
BG04.02.2010
GR05.02.2010
CH28.02.2010
LI28.02.2010
MC01.03.2010
IS04.03.2010
PT04.03.2010
Former [2010/46]AT04.11.2009
BE04.11.2009
CY04.11.2009
CZ04.11.2009
DK04.11.2009
EE04.11.2009
FI04.11.2009
LT04.11.2009
PL04.11.2009
RO04.11.2009
SE04.11.2009
SI04.11.2009
SK04.11.2009
BG04.02.2010
GR05.02.2010
MC01.03.2010
IS04.03.2010
PT04.03.2010
Former [2010/39]AT04.11.2009
BE04.11.2009
CY04.11.2009
CZ04.11.2009
DK04.11.2009
EE04.11.2009
FI04.11.2009
LT04.11.2009
PL04.11.2009
RO04.11.2009
SE04.11.2009
SI04.11.2009
SK04.11.2009
BG04.02.2010
IS04.03.2010
PT04.03.2010
Former [2010/31]AT04.11.2009
BE04.11.2009
CY04.11.2009
FI04.11.2009
LT04.11.2009
PL04.11.2009
SE04.11.2009
SI04.11.2009
IS04.03.2010
PT04.03.2010
Former [2010/30]AT04.11.2009
CY04.11.2009
FI04.11.2009
LT04.11.2009
PL04.11.2009
SE04.11.2009
SI04.11.2009
IS04.03.2010
PT04.03.2010
Former [2010/25]CY04.11.2009
FI04.11.2009
LT04.11.2009
PL04.11.2009
SE04.11.2009
SI04.11.2009
IS04.03.2010
PT04.03.2010
Former [2010/23]FI04.11.2009
LT04.11.2009
PL04.11.2009
SE04.11.2009
SI04.11.2009
IS04.03.2010
PT04.03.2010
Former [2010/21]LT04.11.2009
SE04.11.2009
IS04.03.2010
PT04.03.2010
Cited inInternational search[A]WO03099284  (AMGEN INC [US], et al) [A] 1-14* claims 1,6 *;
 [PX]WO2004014871  (AMGEN INC [US], et al) [PX] 1-14 * examples 221,222; claims 1,5 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.